Immunomodulation of cancer: potential use of selectively replicating agents
AUTOR(ES)
Agha-Mohammadi, Siamak
FONTE
American Society for Clinical Investigation
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=315454Documentos Relacionados
- Use of preferentially replicating bacteria for the treatment of cancer
- Early oral contraceptive use and breast cancer: theoretical effects of latency.
- Prostasin, a potential tumor marker in ovarian cancer: a pilot study
- Novel targeted agents for the treatment of bladder cancer: translating laboratory advances into clinical application
- Hyporeactivity of Infection: Potential Limitation to Therapeutic Use of Interferon-Inducing Agents